Publications (580) Jose Maria Eiros Bouza publications

2024

  1. Analyzing Changes in Attitudes and Behaviors towards Seasonal Influenza Vaccination in Spain’s Adult Population over Three Seasons

    Vaccines, Vol. 12, Núm. 10

  2. Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain

    International Journal of Infectious Diseases, Vol. 143

  3. Corrigendum: Impaired antigen-specific B-cell responses after Influenza vaccination in kidney transplant recipients receiving co-stimulation blockade with Belatacept (Front. Immunol., (2022), 13, (918887), 10.3389/fimmu.2022.918887)

    Frontiers in Immunology

  4. Disseminated nocardiosis

    Revista Espanola de Quimioterapia

  5. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

    Eurosurveillance, Vol. 29, Núm. 6

  6. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

    Journal of Headache and Pain, Vol. 25, Núm. 1

  7. Gastroenteritis víricas.

    Medicina interna (Elsevier España), pp. 2491-2496

  8. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

    IJID Regions, Vol. 10, pp. 146-149

  9. Impact of age on the transmission of SARS-CoV-2 in healthcare workers: Influence of nonoccupational risk factors

    Wiener Klinische Wochenschrift, Vol. 136, Núm. 15-16, pp. 439-448

  10. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

    Scientific Reports, Vol. 14, Núm. 1

  11. Importancia de los Centros Nacionales de Gripe en la vigilancia de virus aviares de alta patogenicidad. El momento para One-Health es ahora

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 121-126

  12. Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study

    European Journal of Neurology, Vol. 31, Núm. 8

  13. Incremento de infecciones respiratorias agudas graves en niños durante la última etapa de la pandemia COVID-19

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 58-68

  14. MiRNome Profiling of Extracellular Vesicles in Patients with Severe COVID-19 and Identification of Predictors of Mortality

    Journal of Infectious Diseases, Vol. 230, Núm. 4, pp. 901-911

  15. Microbiological and epidemiological features of respiratory syncytial virus

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 209-220

  16. Otras viriasis respiratorias.

    Medicina interna (Elsevier España), pp. 2502-2508

  17. Potential Effects on Elderly People From Nirsevimab Use in Infants

    Open Respiratory Archives, Vol. 6, Núm. 2

  18. Quantification of bacterial DNA in blood using droplet digital PCR: a pilot study

    Diagnostic Microbiology and Infectious Disease, Vol. 108, Núm. 1

  19. RSV Risk Profile in Hospitalized Adults and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy, Vol. 13, Núm. 9, pp. 1983-1999

  20. Respiratory Syncytial Virus Risk Profile in Hospitalized Infants and Comparison with Influenza and COVID-19 Controls in Valladolid, Spain, 2010–2022

    Infectious Diseases and Therapy, Vol. 13, Núm. 11, pp. 2395-2413